Author: Ken Dropiewski

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Financial by Comments are Disabled

CHARLESTOWN, Mass., April 03, 2024 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced the grant of inducement awards to two newly hired employees. These grants were made pursuant to the Company’s 2024 Inducement Stock Incentive Plan and were made as an inducement material to each employee’s acceptance of employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).

Continue Reading →

Viz.ai® Announces Three New Studies Supporting Viz HCM™ Module for the Detection and Management of Suspected Hypertrophic Cardiomyopathy

Coronary/Structural Heart by 0 comments

April 03, 2024 08:00 AM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data supporting advancements in cardiology care. Three studies, presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo 2024, have shown positive […]

Continue Reading →

GE HealthCare Introduces Caption AI on Vscan Air SL Wireless Handheld Ultrasound System to Help More Clinicians Capture Diagnostic-Quality Cardiac Images

Coronary/Structural Heart Radiology by 0 comments

April 03, 2024 08:00 AM Eastern Daylight Time CHICAGO–(BUSINESS WIRE)–GE HealthCare (Nasdaq: GEHC) today announced the launch of Caption AI artificial intelligence (AI)-driven software for rapid cardiac assessments at the point of care on Vscan Air SL. Now, with Caption AI technology, clinicians using Vscan Air SL handheld ultrasound will […]

Continue Reading →

InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference

Peripheral/Endo by Comments are Disabled

TEL AVIV, Israel and MIAMI, April 03, 2024 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that Marvin Slosman, Chief Executive Officer, will deliver a company update presentation at the 23rd Annual Needham Virtual Healthcare Conference, which is being held April 8-11, 2024.

Continue Reading →

Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives

Uncategorized by 0 comments

IRVINE, Calif., April 02, 2024 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), today announced the appointment of Tim Benner as Senior Vice President of U.S. Sales and Dr. Andrew Niekamp as Vice President of Medical Affairs. Mr. Benner will be responsible for developing effective strategies across the company’s […]

Continue Reading →

Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS

Uncategorized by Comments are Disabled

SUNNYVALE, Calif., April 02, 2024 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the launch of its ENROUTE® Transcarotid Neuroprotection System PLUS (“NPS PLUS”), a key component of the TCAR® portfolio. This next generation device builds upon the prior ENROUTE Transcarotid Neuroprotection System to deliver smoother arterial sheath insertion, greater flow precision, and a simplified prep experience for surgical teams, all while maintaining unparalleled neuroprotection during the TCAR procedure.

Continue Reading →

Transverse Medical Appoints David C. Blowers to Board of Directors, Dr. Rahul Sharma as Independent Member, Carl St. Bernard rejoins Board.

Financial by 0 comments

DENVER–(BUSINESS WIRE)–Point-Guard Protected™ Safeguard the Brain, Treat the Heart. Transverse Medical, Inc., developer of the POINT-GUARD™ Cerebral Embolic Protection medical device to protect the patient from stroke during Transcatheter Aortic Valve Replacement (TAVR) has reorganized the Board of Directors following the recent closing of a Series B1 financing. Transverse Medical […]

Continue Reading →

Protembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal Trial

Coronary/Structural Heart by 0 comments

NEW YORK & AACHEN, Germany–(BUSINESS WIRE)–Protembis GmbH (Protembis), a privately-held emerging cardiovascular medical device company, announced today the enrollment of the first patient in the PROTEMBO Investigational Device Exemption (IDE) Pivotal Trial (NCT05873816). The trial will enroll between 250-500 randomized patients undergoing transcatheter aortic valve replacement (TAVR) in the USA […]

Continue Reading →

Vektor Medical Announces Publication of vMap Study Results in Journal of Cardiovascular Electrophysiology

Rhythm by 0 comments

SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology, today announced the publication of data in the Journal of Cardiovascular Electrophysiology (JACE) demonstrating vMap’s ability to reduce the time from mapping to treatment, procedure duration, and fluoroscopy when treating cardiac arrhythmia patients with ablation therapy. “A 22.6% reduction in […]

Continue Reading →

HeartSciences to Present at the LD Micro Invitational XIV Conference

Coronary/Structural Heart by Comments are Disabled

Southlake, TX, April 02, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences  (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that Chief Executive Officer Andrew Simpson is scheduled to present at the LD Micro Invitational XIV Conference on Tuesday April 9, 2024 at 5:00pm ET at the Sofitel New York. Mr. Simpson will also be hosting one-on-one meetings through the conference.

Continue Reading →
1 … 274 275 276 277 278 … 1,331